🔎 Trials Near Me

Home › Lymphoma › Arizona › Phoenix

Pag-aaral pangklinika para sa Lymphoma sa Phoenix, AZ

Isang pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Phoenix. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Nagre-recruitPhase 2
  • Banner MD Anderson Cancer Center, Phoenix
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07221500

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Nagre-recruitPhase 1/2
  • St. Joseph's Hospital and Medical Center, Phoenix
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT03328078

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Nagre-recruitPhase 1/2
  • Phoenix Childrens Hospital, Phoenix
12 Months – 21 Years · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04870944

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Nagre-recruitPhase 1/2
  • Mayo Clinic, Phoenix
Edad 12 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT04588922

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2
  • Mayo Clinic, Phoenix
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Nagre-recruitObservasyonal na pag-aaral
  • Phoenix Childrens Hospital, Phoenix
Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

Nagre-recruitPhase 2
  • Mayo Clinic Arizona, Phoenix
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT06854003

Pag-aaral para sa Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Phoenix

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.